347 articles on leadership, communication and professional development.
FDA approves pirtobrutinib (Jaypirca) for CLL and SLL in adults. Learn about the benefits, safety, and BRUIN study data in this article.
Accelerated approvals: early access to cancer therapies based on initial evidence while confirmatory studies are completed.
Drug Trials Snapshots summarize studies of new medications and show who participated, their results and effects helping to better understand each treatment
Lynozyfic offers a new option for treating multiple myeloma, with good clinical results and risks that require medical monitoring.
New treatment for immunoglobulin A nephropathy that reduces proteinuria and offers a promising option while its effects are being evaluated.
The FDA issued an important alert: they found counterfeit units of Ozempic within the official drug supply chain in the United States.
FDA approves Darzalex Faspro (daratumumab + hyaluronidase) for high-risk smoldering multiple myeloma; learn about AQUILA evidence, dosage, benefits and risks.
Practical guide to transform KOLs, sales teams, and leaders into memorable communicators who connect with their audience and drive action through storytelling.
In 2024, Bayer incorporated the Dynamic Shared Ownership (DSO) model to gain agility.
Leaderlix joined forces with the integrity committee at Audi Mexico, made up of key leaders from Audi and Volkswagen, to orchestrate the Integrity program.
Learn to communicate with impact using Conversation Levels: avoid the expert's blind spot.
Persuading in media is not magic: it's technique. Learn 4 key factors —cognitive fluency, nonverbal coherence, strategic structure, and medium adaptation— that make your audience believe you.
Discover what changes when speaking with TV, radio, press, podcasts or social media. Compare formats, risks and audiences, and evaluate which media are your strongest.
Learn how to predispose trust in your audience before a media interview using an Impact Bio: what it is, how to write it and present it.
Explore in depth the phenomenon of voice confrontation: the neuroacoustic reason why your recorded voice sounds so different
Lenacapavir shows 96% efficacy in HIV prevention in the PURPOSE 2 study.
Novo Nordisk completes the acquisition of Catalent for 10.659 billion euros. The operation includes three new plants to boost Wegovy production and.
Discover chronic GVHD, a little-known disease that affects many bone marrow transplant recipients. Learn about its symptoms and the importance of awareness.
Neuralink launches the CONVOY trial to test robotic arm control through brain implants.
Amgen's MariTide clinical trial results disappoint, with 20% weight loss and higher dropout rate compared to competitors like.